Trombophilic screening for nonarteritic anterior ischemic optic neuropathy

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 244, Issue 1, 2006, Pages 3-8

  Nagy, Valeria ^a   Steiber, Zita ^a   Takacs, Lili ^a   Vereb, Gyorgy ^a   Berta, Andras ^a   Bereczky, Zsuzsanna ^a   Pfliegler, Gyorgy ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Anterior ischemic optic neuropathy; NAION; Risk factors; Thrombophilia

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8C; CARDIOLIPIN ANTIBODY; FIBRINOGEN; LIPOPROTEIN A; PLASMINOGEN; PROTEIN C; PROTEIN S; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE MUTATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; ISCHEMIC OPTIC NEUROPATHY; LOGISTIC REGRESSION ANALYSIS; MALE; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SCREENING TEST; THROMBOPHILIA;

AGED; BLOOD COAGULATION FACTORS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERTENSION; LIPOPROTEIN(A); MALE; MIDDLE AGED; OPTIC NEUROPATHY, ISCHEMIC; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; THROMBOPHILIA;

EID: 29544444468     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-005-1154-5     Document Type: Article

References (33)

1. Abu El-Asrar AM, Al Rashed SA, Gader AGMA (2000) Anterior ischemic optic neuropathy associated with central retinal vein occlusion. Eye 14:560-562
2. Acheson JF, Sanders MD (1994) Coagulation abnormalities in ischemic optic neuropathy. Eye 8:89-92
3. Aparicio S, Dahlbäck B (1996) Molecular mechanism of activated protein C resistance. Properties of factor V isolated from an individual with homozygosity for the Arg 506 to Gln mutation in the factor V gene. Biochem J 15:467-472
4. Beck RW, Servais GE, Hayreh SS (1987) Anterior ischemic optic neuropathy IX. Cup to disc ratio and its role in pathogenesis. Ophthalmology 94:1503-1508
5. Beck RW, Hayreh SS, Podhajsy BSN, Tan ES, Moke PS (1997) Aspirin therapy in nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 123:212-217
6. Beri M, Klugman MR, Kohler JA, Hayreh SS (1987) Anterior ischemic optic neuropathy VII. Incidence of bilaterality and various influencing factors. Ophthalmol 94:1020-1028
7. Bertina RN, Koeleman BPC, Reitsma PH (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-67 10.1038/369064a0
8. Clauss A (1957) Gerinnungsphysiologische schnell Methode zur Bestimmung des Fibrinogens. Acta Hematol 17:237
9. Cursiefen C, Schönherr U, Schwender S, Grossmann R (1999) Recurrent optic nerve head infarctions associated with combined factor V Leiden-and factor II: G20210A-mutation. Acta Ophthalmol Scand 77:625-627
10. 506Q mutation is a common risk factor for venous thrombosis. Thromb Haemost 78:483-88
11. Dahlbäck B (1999) Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation. Semin Thromb Hemost 25:273-278
12. Dugi KA, Rader DJ (2000) Lipoproteins and the endothelium: Insights from clinical research. Semin Thromb Hemost 26:513-519
13. Fegan CD (2002) Central retinal vein occlusion and thrombophilia. Eye 16:98-106
14. Haralampos JM, Winder AF, Mikhalidis DP (2000) Lipoprotein (a) and stroke. J Clin Pathol 53:487-496
15. Hayreh SS (1974) Anterior ischaemic optic neuropathy. Br J Ophthalmol 58:955-963
16. Hayreh SS, Joos KM, Podhajsky PA, Long CR (1994) Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 118:766-780
17. Hayreh SS, Patricia A, Podhajsky PA, Zimmerman B (1997) Nonarteritic anterior ischemic optic neuropathy: Time of onset of visual loss. Am J Ophthalmol 124:641-647
18. Hayreh SS, Podhajsky PA, Zimmerman B (1998) Ocular manifestations of giant cell arteritis. Am J Ophthalmol 125:509-519
19. The Ischemic Optic Neuropathy Trial Research Group (1995) Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA 273:625-632
20. Koster T, Blann AD, Briet E (1995) Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345:152-155
21. Kostner GM, Steinmetz A (1997) Standardization of Lp(a) measurements. Clin Genet 52:393-397
22. Mojom DS, Hedges TR, Ehrenberg B (2002) Association between sleep apnea syndrome and nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol 120:601-605
23. Murata M, Saito T, Takahashi S, Ichinose A (1998) Plasma lipoprotein(a) levels are high in patients with central retinal artery occlusion. Thromb Res 91:169-175
24. Müller HM, Diekstall FF, Schmidt E, Martz W, Canzler H, Demeler U (1992) Lipoprotein (a): A risk factor for retinal vascular occlusion. German J Ophthalmol 1:338-341
25. Nowak GU, Junker R, Hartmeier M (1999) Increased lipoprotein(a) is an important risk factor for venous thromboembolism in chilhood. Circulation 100:743-748
26. Repka MX, Savino PJ, Schatz NJ, Sergott RC (1983) Clinical profile and long-term implications of anterior ischemic optic neuropathy. Am J Ophthalmol 96:478-483
27. Salomon O, Huna-Baron R, Kurtz S, Steinberg DM, Moisseiev J, Rosenberg N (1999) Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy. Ophthalmology 106:739-742
28. Salomon O, Huna- Baron R, Steinberg DM, Kurtz S, Seligsohn U (1999) Role of aspirin in reducing the frequency of second eye involvement in patients with non-arteritic anterior ischaemic optic neuropathy. Eye 13:357-359
29. Salomon O, Rosenberg N, Steinberg DM, Huna-Baron R, Moisseiev J, Dardic R et al. (2004) Nonarteritic anterior ischemic optic neuropathy is associated with a specific platelet plymorphism located on the glycoprotein Iba gene. Ophthalmol 111:184-188
30. Talks SJ, Chong NHV, Gibson JM, Dodson PM (1995) Fibrinogen, cholesterol and smoking as risk factors for non-arteritic anterior ischemic optic neuropathy. Eye 9:85-88
31. Vine AK, Samana MM (1997) Screening for resistance to activated protein C and mutant gene for factor V:506 in patients with central retinal vein occlusion. Am J Ophthalmol 124:673-676
32. Zivelin A, Rosenberg N, Faier S (1998) A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene. Blood 92:1119-1124
33. Zöller B, Hillap A, Berntorp E (1997) Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosis. Annu Rev Med 48:45-58